Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from...

FDA Recall #Z-1008-2023 — Class II — December 15, 2022

Recall #Z-1008-2023 Date: December 15, 2022 Classification: Class II Status: Ongoing

Product Description

Revogene SARS-CoV-2_IVD real-time RT-PCR test intended for the qualitative detection of RNA from SARSCoV-2 Catalog Number: 410700

Reason for Recall

Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2

Recalling Firm

Meridian Bioscience Inc — Cincinnati, OH

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Devices

Product Quantity

92 kits

Distribution

US Nationwide distribution in the states of AZ, CA, IN, KS, KY, LA, MI, MN, NC, NY, OR, TX.

Code Information

UDI: N/A Lot Numbers 410700P019, 410700P020, 410700P021, 410700P022, 410700P023, 410700P024, 410700P027

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated